# Sutro Biopharma, Inc.: Form 8-K, filed Nov 15, 2018

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2018-11-15
- Accepted by EDGAR: Nov 14, 2018, 20:12 ET
- Period: 2018-11-14
- Accession: 0001193125-18-326967
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/d493238d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/d493238d8k.htm

Filed Nov 15, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-326967. Last ingested by Listed: Nov 13, 2026, 16:35 ET. No prices; not investment advice.
